Natasha Girgis
Company: Cue Biopharma
Job title: Director
Seminars:
Showcasing CUE-401: A Novel TGF-β/ IL-2 Fusion Protein for the Induction & Expansion of FOXP3+ Regulatory T Cells 4:15 pm
Exploring TGF-β and IL-2 as two key signals for the induction of regulatory T cell populations Developing CUE-401 as a novel TGF-β and IL-2 directed therapy for the selective expansion of regulatory T cells in vivo Unearthing the mechanism of action and the activity of CUE-401 New Data!Read more
day: Conference Day One